FdaApplication
NDA 022161
Identifiers
- fda_app_no: NDA022161
Properties
| Property | Value |
|---|---|
| applicant_name | ASTELLAS PHARMA US INC |
| application_type | NDA |
| approval_date | 2008-04-10 |
Products (1)
| Product | Active ingredient | Strength | Dosage form |
|---|---|---|---|
| LEXISCAN | REGADENOSON | 0.4MG/5ML (0.08MG/ML) | SOLUTION;INTRAVENOUS |
1 product